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ABSTRACT
Objectives To test the feasibility of using a new activity 
pacing framework to standardise healthcare professionals’ 
instructions of pacing, and explore whether measures 
of activity pacing/symptoms detected changes following 
treatment.
Design Single- arm, repeated measures study.
Setting One National Health Service (NHS) Pain Service in 
Northern England, UK.
Participants Adult patients with chronic pain/fatigue, 
including chronic low back pain, chronic widespread 
pain, fibromyalgia and chronic fatigue syndrome/myalgic 
encephalomyelitis.
Interventions Six- week rehabilitation programme, 
standardised using the activity pacing framework.
Outcome measures Feasibility was explored via patients’ 
recruitment/attrition rates, adherence and satisfaction, 
and healthcare professionals’ fidelity. Questionnaire 
data were collected from patients at the start and end of 
the programme (T1 and T2, respectively) and 3 months’ 
follow- up (T3). Questionnaires included measures of 
activity pacing, current/usual pain, physical/mental fatigue, 
depression, anxiety, self- efficacy, avoidance, physical/
mental function and quality of life. Mean changes in 
activity pacing and symptoms between T1- T2, T2- T3 and 
T1- T3 were estimated.
Results Of the 139 eligible patients, 107 patients 
consented (recruitment rate=77%); 65 patients completed 
T2 (T1- T2 attrition rate=39%), and 52 patients completed 
T3 (T1- T3 attrition rate=51%). At T2, patients’ satisfaction 
ratings averaged 9/10, and 89% attended ≥5 rehabilitation 
programme sessions. Activity pacing and all symptoms 
improved between T1 and T2, with smaller improvements 
maintained at T3.
Conclusion The activity pacing framework was feasible 
to implement and patients’ ability to pace and manage 
their symptoms improved. Future work will employ a 
suitable comparison group and test the framework across 
wider settings to explore the effects of activity pacing in a 
randomised controlled trial.
Trial registration number NCT03497585.
INTRODUCTION
Activity pacing is a principal coping strategy 
for patients with long- term conditions, 
including chronic low back pain, chronic 
widespread pain, fibromyalgia and chronic 
fatigue syndrome/myalgic encephalomyelitis 
(CFS/ME).1–5 Chronic pain and chronic 
fatigue are known to coexist,6 7 and overlap in 
symptoms, including depression, anxiety and 
disability.8–11 Conditions of chronic pain/
fatigue may share similar disease processes: 
physical deconditioning following under-
activity/avoidance, pathophysiological/
psychological processes and central sensitisa-
tion.11–16 Treatments aim to reverse some of 
these processes: to improve physical/mental 
functioning, increase tolerance and improve 
quality of life.12 15 17 Recommended treat-
ments include psychological therapies (eg, 
cognitive–behavioural therapy) and graded 
exposure to activity/exercise;15 16 of which 
activity pacing is a key component.18–20
Patients with chronic pain/fatigue may 
present with altered behaviours, including 
underactivity or avoidance of activities that 
are perceived as harmful or that may exac-
erbate symptoms; overactivity or excessive 
persistence to push through/distract from 
symptoms; or fluctuations between over-
activity and underactivity.21 Activity pacing 
provides an alternative behaviour to enable 
Strengths and limitations of this study
 ► This was the first study to test the feasibility of using 
a newly developed activity pacing framework in a 
rehabilitation programme to standardise the clinical 
instructions of activity pacing to patients with chron-
ic pain/fatigue.
 ► This feasibility study recruited to target with satis-
factory recruitment/attrition rates.
 ► A comprehensive measure of activity pacing: the 
28- item Activity Pacing Questionnaire, and range of 
validated psychometric measures were suitable to 
detect changes before and after treatment.
 ► This study was not powered with a control arm to 
determine treatment effectiveness.
 ► The generalisability of this study is limited to a sam-
ple of predominantly females, of white ethnic origin, 
and from a single Pain Service.
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patients to (re- )engage with activities in a manner that 
encourages their progression towards more regular or 
improved functioning.4 22 23
At present, there remains confusion regarding how 
activity pacing is defined or interpreted, and the effects 
on patients’ symptoms.5 24 25 There is no widely used guide 
to standardise how healthcare professionals instruct 
activity pacing to patients; and uncertainty whether 
different methods are required for symptoms of chronic 
pain versus chronic fatigue.3 26 This poses challenges how 
to advise patients with both chronic pain and fatigue.
We have developed an activity pacing framework using 
an inclusive approach for patients who present at reha-
bilitation services with chronic pain and/or fatigue. 
Using the Medical Research Council guidelines for 
developing complex interventions, mixed methods were 
implemented to encompass theoretical and stakeholder 
standpoints.27 Mixed methods comprise quantitative and 
qualitative approaches to collecting and analysing data.28 
Stage I: Healthcare professionals’ survey gathered opin-
ions on activity pacing (n=92).4 These findings, together 
with existing research formed the first draft of the frame-
work and accompanying appendices. Stage II: Nominal 
group technique refined the activity pacing framework 
using a consensus meeting between patients and health-
care professionals (n=10).29 During the development 
of the activity pacing framework, stakeholders included 
healthcare professionals and patients with the aim of 
increasing the clinical utility and acceptability of the 
framework (see online supplemental figure 1 Content 
of the Activity Pacing Framework: Theory and Overview, 
and Appendices and Teaching Guide booklets.)
The conceptual model of the activity pacing framework 
(see figure 1) follows principles of quota- contingency 
and the operant approach (eg, setting goals according 
to time/distance/activity). The activity pacing frame-
work is underpinned by concepts of rehabilitation with 
aims of improving physical and cognitive function; and 
engagement in, and satisfaction with meaningful activi-
ties, while managing symptoms.4 29 The activity pacing 
framework includes the potential for reversibility of some 
of the consequences of chronic pain/fatigue, such as 
the potential to reduce levels of disability. Together with 
containing themes of adjusting activities, planning and 
consistency, the activity pacing framework also includes 
themes of progression regarding the amount and/or 
variety of activities. Therefore, the activity pacing frame-
work is considered to be a rehabilitative approach that 
moves forward from only adapting, or in some cases mal- 
adapting to the long- term condition. The activity pacing 
framework differs from energy conservation/adaptive 
pacing approaches which involve undertaking activities 
according to symptom severity (symptom- contingency) 
with an aim of reducing or avoiding symptoms.30 31 Within 
the current activity pacing framework, quota- contingency 
is advised alongside concepts of flexibility and choice to 
enable relevance and sustainability in conditions where 
symptoms may vary. The framework refers to all types of 
activities including work, household activities, cognitive 
activities, physical activities, exercise and relaxation to 
increase its wider relevance for patients with chronic pain 
and/or fatigue, for varying abilities and behaviours.
The aim of this study was to test the feasibility of using 
the activity pacing framework to underpin a rehabilita-
tion programme for chronic pain/fatigue. In prepara-
tion for a future clinical trial, specific objectives included: 
(1) Exploring participant recruitment/attrition rates 
and adherence/acceptability (for both chronic pain and 
fatigue); (2) Exploring healthcare professionals’ fidelity 
to the framework and (3) Exploring the suitability of 
the outcome measures, including the modified 28- item 
Activity Pacing Questionnaire (APQ- 28).
METHODS
Study design
This single- arm, repeated measures study is reported as 
a non- randomised feasibility study using the extended 
Consolidated Standards of Reporting Trials guide-
lines,32 33 (see online supplemental table 1). Quantita-
tive questionnaire data were collected from patients at 
the start (T1) and end (T2) of the 6- week rehabilitation 
programme, and at 3- month follow- up (T3). The study 
was prospectively registered (protocol available at  Clin-
icalTrials. gov: NCT03497585). The acceptability of the 
Figure 1 Activity pacing conceptual model taken from the 
activity pacing framework.
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framework, explored via interviews with patients and 
healthcare professionals, is reported elsewhere.34
Participant recruitment
Participants were identified from consecutive referrals 
to a rehabilitation programme for chronic pain/fatigue 
in a Pain Service in Northern England, UK. All patients 
attended a minimum of one face- to- face appointment 
before referral to the programme. Participants received 
the study information via the post 1 week before attending 
the programme and/or during the first session of the 
programme. The consent form was completed either at 
home or during the first session.
Eligibility criteria
Eligible patients were aged ≥18 years, with symptoms 
for ≥3 months and with a general practitioner or hospital 
consultant diagnosis of chronic low back pain, chronic 
widespread pain, fibromyalgia or CFS/ME. Patients 
were required to read and write in English. Ineligible 
patients were those with evidence of a serious under-
lying pathology, such as a current diagnosis of cancer, 
or patients with severe mental health or cognitive func-
tioning issues.
Sample size
A sample size of 50 patients has been recommended for 
feasibility studies to enable estimates of recruitment/
attrition, means/SD and changes in means to prepare 
for future clinical trials.35 To attain a sample of 50 partic-
ipants at T3, it was estimated that 340 patients may need 
to be approached to allow for a 50% recruitment rate at 
T1, a 40% attrition rate between T1 and T2 and a 50% 
return rate at T3.
Existing rehabilitation programme
The existing rehabilitation programme comprised of six 
consecutive weekly sessions (each 3.5 hours) delivered 
by healthcare professionals (pain specialist physiother-
apists and psychological well- being practitioners). The 
programme included understanding complex symptoms, 
sleep hygiene, graded exercise, goal setting, relaxation 
and mindfulness. Pacing was instructed in one session but 
was not informed or standardised by any particular guide 
or framework.
Activity pacing framework standardised programme
The existing 6- week programme was modified though 
restructuring and standardisation using the activity 
pacing framework. Activity pacing was formally instructed 
on two sessions (weeks 2–3). However, activity pacing 
was referenced throughout the programme in relation 
to other coping strategies, for example, how activity 
pacing can assist graded exercise (weeks 1–5) or set- back 
management (week 6). In comparison to the existing 
rehabilitation programme, the activity pacing frame-
work standardised programme included more in- depth 
discussions of activity behaviours (avoidance, overactivity- 
underactivity cycling and excessive persistence) to assist 
patients to identify their current approach to activities. 
This aimed to facilitate patients’ recognition of which 
facets of activity pacing were most relevant to them. The 
two activity pacing sessions focused on the aims of activity 
pacing, barriers to activity pacing, facets of activity pacing 
(eg, breaking down tasks, switching between activities, 
having more consistent activity levels, allowing flexibility, 
gradually increasing the amount or variety of activities), 
and stages of activity pacing (introducing activity pacing, 
finding baselines, adjusting activities, planning, consis-
tency, learning and progressing). Practical exercises 
included completing an activity diary to discuss patients’ 
activity patterns and setting goals in which activity pacing 
could be practised (see online supplemental figure 2. 
Content of the rehabilitation programme). Patients 
received a handout to summarise the key concepts of 
activity pacing. The healthcare professionals (as above) 
received training on the framework during a half- day 
session and could contact the lead researcher (DA) 
for any queries. All patients attended the standardised 
programme, but patients chose whether to participate in 
the study through their optional completion of the study 
questionnaires and consent form.
Data collection
Feasibility outcomes
Measures of feasibility included participant recruitment/
attrition rates, adherence (number of sessions attended), 
acceptability (two satisfaction rating scales regarding the 
programme content and length where 0=dissatisfied and 
10=fully satisfied), and missing data in the questionnaire. 
For every programme, healthcare professionals completed 
a 13- item fidelity checklist based on the conceptual model 
of the activity pacing framework to ensure their inclusion 
of key elements from the framework. Each clinician was 
observed once by the lead researcher.
Clinical measures
The self- reported paper questionnaire booklets (T1, T2 
and T3) included standardised clinical measures. T1 
could be completed during session one or at home, T2 
could be completed during session 6, and T3 was sent in 
the post to be completed at home. Telephone reminders 
were made if the T3 questionnaires were not returned 
within 2 weeks. The T1 booklet contained demographic 
questions, in addition to following measures included in 
T2 and T3:
1. Activity pacing was measured using the APQ- 28. The 
26- item APQ was initially validated among patients with 
chronic pain/fatigue and contained five subthemes: 
Activity adjustment, Activity planning, Activity con-
sistency, Activity acceptance and Activity progression 
(Cronbach’s alpha=0.72–0.92).36 (see online supple-
mental table 2, Five themes of the APQ- 28 with exam-
ples.) Each item is scored between 0=‘never did this’ 
and 4=‘always did this’. Two items have been added 
that correspond to important aspects of activity pacing 
that emerged during the development of the activity 
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pacing framework. The new items: APQ12: ‘I found a 
baseline amount of activities that I could do on ‘good’ 
and ‘bad’ days’ and APQ15: ‘I had a flexible approach 
with my activities’ were added to the subthemes of best 
conceptual fit (activity adjustment and activity accep-
tance, respectively). Each subtheme was calculated 
as a mean score. The APQ- 28 subthemes, similarly to 
the following scales, permitted one missing item per 
subscale.
2. Current and usual pain were measured using two 
11- point Numerical Rating Scales, where 0=‘no pain’ 
and 10=‘worst possible pain’.37
3. Physical fatigue (seven items) and mental fatigue (four 
items) were measured using the Chalder Fatigue Ques-
tionnaire, where scores of 1=‘much worse than usual’ 
and 4=‘better than usual’.38 Two subscale scores were 
summated where higher scores indicated less fatigue.
4. Depression was measured using the nine- item Patient 
Health Questionnaire- 9, the items of which are based 
on the Diagnostic and Statistical Manual of Mental 
Disorders Fourth Edition.39 Items were rated between 
0=‘not at all’ and 3=‘nearly everyday’. Total scores 
of 1–4=minimal depression, 5–9=mild depression, 
10–14=moderate depression and ≥15=severe depres-
sion.39 40
5. Anxiety was measured using the seven- item Gener-
alised Anxiety Disorder Assessment. Items were rated 
between 0=‘not at all’ and 3=‘nearly everyday’. Total 
scores of 5–9=mild anxiety, 10–14=moderate anxiety 
and ≥15=severe anxiety.41
6. Self- efficacy was measured using the 10- item Pain Self- 
Efficacy Questionnaire (PSEQ) where items were rat-
ed between 0=‘not at all confident’ and 6=‘completely 
confident’. Total scores of PSEQ ≥40 indicate those pa-
tients who are more likely to continue implementing 
coping strategies/behavioural changes and PSEQ ≤16 
are considered low.42
7. Avoidance was measured using the ‘Escape and Avoid-
ance’ subscale of the Pain Anxiety Symptoms Scale- 
short version (PASS- 20).43 The five items were rated 
between 0=‘never’ and 5=‘always’ where higher total 
scores indicated greater avoidance.
8. Physical and mental function were measured using 
the 12- Item Short- Form Health Survey (SF- 12). Two 
subscale scores (out of 100) were calculated using the 
SF- 12 software (V.2; 1- week recall) where higher scores 
indicated better function.44
9. Health- related quality of life was measured using the 
EQ- 5D- 5L (EuroQol five- dimensions, five- levels). The 
EQ- 5D- 5L was calculated as an index score.45 46
Data analysis
Feasibility outcomes and participants’ demographics were 
analysed using descriptive statistics. Clinical outcomes 
were estimated as changes in activity pacing and symp-
toms between T1- T2, T2- T3 and T1- T3 (mean change, 
95% CIs). The validity of the modified APQ- 28 was esti-
mated using Cronbach’s alpha and item correlations; and 
sensitivity analyses explored the effects of including the 
two new APQ- 28 items. Data were analysed using IBM 
SPSS Statistics V.26 statistical software (IBM).
Patient and public involvement
Patient and public involvement (PPI) commenced 
during the initial planning stages of the mixed methods 
programme to develop and test the activity pacing 
framework. A meeting with five PPI representatives 
discussed the study purpose and practical issues around 
the proposed methods (online survey, nominal group 
technique and feasibility and acceptability studies). PPI 
guided on improving the accessibility of patients’ partic-
ipation and reducing burden (eg, location and duration 
of meetings). A PPI representative has acted as an advisor 
on the study, involving commenting on study docu-
ments/questionnaire booklets and coding qualitative 
interviews. Acceptability interviews with patients explored 
practical issues surrounding the feasibility study,34 which 
will further assist the planning of a future randomised 
controlled trial (RCT) of activity pacing.
RESULTS
Recruitment and T1 data collection commenced in May 
2018 and T3 data collection ended in December 2019 
due to attaining the target sample.
Demographics
Among the 107 participants who completed the base-
line (T1) measures, participants were predominantly 
female (n=92, 86.0%) with a mean age of 55.25±12.83 
years. Low back pain was most frequently reported 
(n=79, 73.8%) and CFS/ME least frequently reported 
(n=12, 11.2%). Sixty- five participants (61.3%) reported 
two or more conditions of chronic pain and/or 
fatigue. Of the 12 participants with CFS/ME, 10 partic-
ipants reported CFS/ME as their main condition, and 
11 reported at least one comorbidity of LBP (n=7), 
chronic widespread pain (n=6), fibromyalgia (n=7) 
or another condition (n=3). (see table 1 for partici-
pant demographics and table 2 for baseline scores for 
activity pacing and symptoms.)
Feasibility outcomes
Recruitment and attrition (objective 1)
Of the 144 patients invited to participate, 139 were 
eligible (96.5%). The reasons for ineligibility included: 
three patients reported only neck pain, one patient 
reported neck/knee pain and one patient reported 
thoracic pain. Of the 139 eligible patients, 107 
(77.0%) were recruited at T1, 69 (64.5%) completed 
the 6- week programme and 65 (60.7%) completed the 
T2 measures (attrition rate=39.3%). Fifty- two partici-
pants completed T3 (80.0% of T2; attrition rate from 
T1=51.4%). There were no serious adverse events (see 
figure 2).
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Of the 107 participants, the median number of rehabili-
tation programme sessions attended was five (58.9% partic-
ipants attended ≥5 sessions); 83.2% participants attended 
at least one activity pacing session and 56.1% attended 
both activity pacing sessions. Of the 65 participants who 
completed T2, the median number of sessions attended 
was six (89.2% participants attended ≥5 sessions); 100% of 
participants attended at least one activity pacing specific 
session and 54 (83.1%) participants attended both activity 
pacing sessions. There were no statistically significant 
Table 1 Participant demographics at baseline (T1)
Participants who 
completed T1 but not T2
Participants who 
completed T1 and T2 Total
Gender (n=42) (n=65) (n=107)
  Male 6 (14.3%) 9 (13.8%) 15 (14.0%)
  Female 36 (85.7%) 56 (86.2%) 92 (86.0%)







Ethnicity (n=41) (n=65) (n=106)
  White (British, Irish, other) 39 (95.1%) 60 (92.3%) 99 (93.4%)
  Black (Caribbean, African) 0 (0.0%) 1 (1.5%) 1 (0.9%)
  Mixed (white/black, white/Asian, other) 1 (2.4%) 2 (3.1%) 3 (2.8%)
  Asian (Indian, Pakistani, Bangladeshi, 
other)
1 (2.4%) 2 (3.1%) 3 (2.8%)
  Asian Eastern (Chinese, other) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Living situation* (n=42) (n=65) (n=107)
  Lives alone 7 (16.7%) 10 (15.4%) 17 (15.9%)
  Lives with partner 25 (59.5%) 48 (73.8%) 73 (68.2%)
  Lives with children 16 (38.1%) 24 (36.9%) 40 (37.4%)
  Other 2 (4.8%) 1 (1.5%) 3 (2.8%)
Employment (n=42) (n=65) (n=107)
  Working (full time, part time, in the house, 
student)
13 (31.0%) 31 (47.7%) 44 (41.1%)
  Not working (due to chronic pain/fatigue/
other condition)
15 (35.7%) 19 (29.2%) 34 (31.8%)
  Retired/semiretired 14 (33.3%) 14 (21.5%) 28 (26.2%)
  Other 0 (0.0%) 1 (1.5%) 1 (0.9%)
Conditions (n=41) (n=65) (n=106)
  Low back pain 30 (73.2%) 49 (75.4%) 79 (74.5%)
  Widespread pain 19 (46.3%) 33 (50.8%) 52 (49.1%)
  Fibromyalgia 9 (22.0%) 20 (30.8%) 29 (27.4%)
  CFS/ME 6 (14.6%) 6 (9.2%) 12 (11.3%)
  Other 9 (22.0%) 12 (18.5%) 21 (19.8%)
No of the above conditions (n=41) (n=65) (n=106)
  1 17 (41.5%) 24 (36.9%) 41 (38.7%)
  2 19 (46.3%) 30 (46.2%) 49 (46.2%)
  3 3 (7.3%) 9 (13.8%) 12 (11.3%)
  4 1 (2.4%) 1 (1.5%) 2 (1.9%)
  5 1 (2.4%) 1 (1.5%) 2 (1.9%)








*Patients could select more than one answer.
CFS/ME, chronic fatigue syndrome/myalgic encephalomyelitis.
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differences between participants who completed T2 or 
dropped out in terms of demographics or baseline symp-
toms. Of the 12 participants with CFS/ME, six completed 
T2 (50%) and six completed T3 (100% of T2, 50% of 
T1); whereas 59 of the 95 participants without CFS/ME 
completed T2 (62%) and 46 completed T3 (78% of T2 
and 48% of T1).
Acceptability of the rehabilitation programme/questionnaires 
(objective 1)
On T2, participants rated their satisfaction of the length 
and content of the rehabilitation programme as mean=8.8 
(SD=1.7) and 9.1 (SD=1.5), respectively. The satisfaction 
of only those participants with CFS/ME was mean=9.0 
(SD=0.9) and 9.2 (SD=1.0).
There were minimal missing data in the questionnaire 
booklets (approximately 1%). Some participants wrote 
comments regarding their perceived benefits of imple-
menting activity pacing and other coping strategies. 
Two participants wished for a longer programme or a 
follow- up session (see figure 3 for examples of partici-
pants’ comments).
Fidelity to the activity pacing framework (objective 2)
Each healthcare professional observation demonstrated 
good adherence to the framework against a number of key 
points. Healthcare professionals reported 100% adher-
ence in their fidelity checklists for each rehabilitation 
programme. Healthcare professionals reported that some 
participants spent over 20 min completing the question-
naire booklet, and that not all patients completed the 
activity diaries.
Interventions between T2 and T3
Of the 52 respondents at T3, two patients received lumbar 
epidural steroid injections, one patient had acupuncture, 
one attended a chiropractor and one patient had knee 
surgery.
Clinical outcomes
Validity of the APQ-28 (objective 3)
At T1, the two new APQ- 28 items showed ease of comple-
tion through minimal missing answers (Item APQ12=0 
missing answers, Item APQ15=1 missing answer). The 
scores of the new items utilised the full range, and the 
mean scores (Items APQ12=1.67 and APQ15=1.91) sat 
within the range of the other APQ- 28 items (mean=1.17–
2.78). The new items demonstrated optimal fit with 
their allocated subthemes via highest interitem correla-
tions and item- total correlations (item total correlations: 
APQ12 and Activity adjustment, rs(106)=0.76, p<0.001; 
Item APQ15 and Activity acceptance, r(106)=0.68, 
p<0.001). The internal consistency for Activity adjustment 
increased with the addition of Item APQ12 (Cronbach’s 
alpha=0.86 to 0.88), and for activity acceptance with the 
addition of item APQ15 (Cronbach’s alpha=0.68 to 0.72). 
Table 2 Baseline scores for activity pacing and symptoms for all patients completing the baseline questionnaires (T1)
Measures (range of scores)
Baseline scores for those 
completed T1 but not T2:
mean (SD)
Baseline scores for those 
completed T1 and T2:
mean (SD) Total scores
APQ- 28 activity adjustment (0–4) (n=42) 1.96 (0.87) (n=64) 1.74 (0.76) (n=106) 1.83 (0.81)
APQ- 28 activity planning (0–4) (n=42) 1.57 (1.03) (n=65) 1.44 (0.95) (n=107) 1.49 (0.98)
APQ- 28 activity consistency (0–4) (n=42) 1.91 (0.91) (n=65) 1.82 (0.96) (n=107) 1.85 (0.94)
APQ- 28 activity acceptance (0–4) (n=42) 1.97 (1.02) (n=65) 1.87 (0.84) (n=107) 1.91 (0.92)
APQ- 28 activity progression (0–4) (n=42) 1.59 (1.05) (n=65) 1.45 (0.88) (n=107) 1.51 (0.95)
Current pain (0–10) (n=41) 6.83 (1.96) (n=65) 6.63 (1.97) (n=106) 6.71 (1.96)
Usual pain (0–10) (n=40) 7.72 (1.43) (n=63) 7.30 (1.82) (n=103) 7.47 (1.69)
Physical fatigue (7- 28) (n=41) 14.18 (5.12) (n=62) 15.22 (4.10) (n=103) 14.81 (4.54)
Mental fatigue (4- 16) (n=42) 8.79 (3.22) (n=64) 8.86 (2.77) (n=106) 8.83 (2.94)
Depression (0–27) (n=40) 12.63 (7.61) (n=64) 13.66 (6.38) (n=104) 13.26 (6.86)
Anxiety (0–21) (n=41) 9.86 (6.64) (n=65) 9.91 (5.47) (n=106) 9.89 (5.92)
Self- efficacy (0–60) (n=42) 26.26 (13.85) (n=65) 25.29 (10.60) (n=107) 25.67 (11.93)
Avoidance (0–25) (n=42) 12.95 (6.74) (n=64) 13.27 (5.49) (n=106) 13.14 (5.98)
Physical function (0–100) (n=42) 33.67 (9.75) (n=63) 34.15 (8.23) (n=105) 33.96 (8.82)
Mental function (0–100) (n=42) 42.22 (11.51) (n=63) 38.52 (11.10) (n=105) 40.00 (11.36)
Quality of life (0–1) (n=40) 0.41 (0.26) (n=60) 0.43 (0.25) (n=100) 0.42 (0.25)
Activity pacing (APQ- 28), Pain (Numerical Rating Scale 0–10), Physical/mental fatigue (Chalder Fatigue Questionnaire), Depression (Patient 
Health Questionnaire- 9), Anxiety (Generalised Anxiety Disorder- 7), Self- efficacy (Pain Self- Efficacy Questionnaire), Avoidance (Escape and 
avoidance subscale of the Pain Anxiety Symptoms Scale- 20), Physical/mental function (Short- Form 12), Quality of life (EQ- 5D- 5L EuroQol 
five- dimensions, five- levels index score).
APQ- 28, 28- item Activity Pacing Questionnaire.
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The internal consistency of the other APQ- 28 subthemes 
were: activity planning=0.86, activity consistency=0.80 and 
activity progression=0.69.
Mean changes in activity pacing and symptoms (objective 3)
Between T1 and T2, all five APQ- 28 subtheme mean 
scores increased, indicating improved activity pacing. 
There were small reductions in APQ- 28 scores between 
T2 and T3. However, all five subthemes showed overall 
improvements between T1- T3, with Activity planning 
showing the greatest increases (see table 3). Sensitivity 
analyses showed marginal increases in mean changes 
following the addition of the two new APQ- 28 items.
Between T1 and T2, the mean scores of all symptoms 
improved. Current pain reduced more than usual pain. 
Physical and mental fatigue both improved, as did self- 
efficacy and quality of life. Mental function improved 
more than physical function. Depression, anxiety and 
avoidance all reduced. There was some deterioration 
in symptoms between T2- T3, but between T1 and T3 
all symptoms demonstrated clear improvements except 
avoidance (−1.46, 95% CI −3.02 to 0.10) and physical 
function (1.62, 95% CI −0.81 to 4.06) (see table 4). 
Observing only the subgroup of participants with CFS/
ME, improvements were seen between T1- T2 and T1- T3 
across all APQ- 28 subthemes and symptoms.
DISCUSSION
This study fulfilled the original aims of testing the feasi-
bility and acceptability of using a new activity pacing 
framework to standardise instructions of activity pacing 
to assist planning a future effectiveness RCT. The study 
recruited to target and patients with chronic pain and 
chronic fatigue demonstrated both improvements in 
activity pacing strategies and reductions in symptoms.
Feasibility
The activity pacing framework demonstrated feasibility 
through excellent fidelity to the framework by healthcare 
professionals via self- reported checklists and observa-
tions. Acceptability was demonstrated through patients’ 
high satisfaction scores. Not all patients completed the 
activity diaries, however, this was optional for patients to 
facilitate their own self- reflection.
The recruitment rate (77%) was higher than estimated 
in the study protocol (50%). This was similar to a study 
exploring a 5- week exercise programme for chronic hip 
pain (recruitment rate=76%),47; and this rate is consid-
ered ‘Good’ using cut- off levels of 80%=excellent and 
70%=good from a feasibility study exploring a mind- body 
physical activity programme for chronic pain.48 The attri-
tion rate between T1 and T2 (39.3%) was as predicted in 
the protocol (40%), and lower than the 60% attrition rates 
reported across other studies investigating programmes 
for chronic pain.20 The attrition rate between T2 and T3 
Figure 2 CONSORT diagram showing the flow of 
participants through the study. CONSORT, Consolidated 
Standards of Reporting Trials.
Figure 3 Participants’ written comments following attending 
the rehabilitation programme.
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(20.0%) was lower than predicted in the protocol (50%), 
and the target sample size proved feasible to attain. These 
recruitment/attrition rates will help to plan the progres-
sion criteria used in a future pilot RCT of activity pacing.
Regarding treatment adherence, only 56.1% of partic-
ipants recruited at T1 attended both activity pacing 
sessions. Many participants (n=18, 16.8%) dropped out 
after the first session and therefore did not attend any 
activity pacing sessions. Reasons for early drop- out often 
include unrealistic expectations of symptom improve-
ment, low motivation, or confidence to commit to 
programmes or behavioural changes.20 In comparison, 
attendance rates of both activity pacing sessions among 
those who completed T2 were 83.1%, and 89.2% of partic-
ipants attended five or more sessions. This is comparable 
to adherence rates of 81% seen elsewhere,47; and adher-
ence rates have been considered as ‘Excellent’ when 70% 
or more participants complete 75% of sessions.48 However, 
within this study, the interpretation of high attendance 
rates from those who completed T2 are considered more 
modestly following the drop outs after week 1.
Participants reported the condition of low back pain 
most frequently and CFS/ME the least frequently, as per 
current prevalence rates.49 50 Our findings reiterate the 
high occurrence of comorbidities, and frequent coex-
istence of chronic pain among patients with CFS/ME.9 
Participants with CFS/ME demonstrated improvements 
in symptoms following treatment, in comparison to other 
studies in which pacing has been ineffective.31 Disparate 
to the study by White et al31 the activity pacing frame-
work encourages a rehabilitative approach that facilitates 
increased function rather than aiming to reduce symp-
toms. The effects of rehabilitative approaches to activity 
pacing for patients with both chronic pain and fatigue 
requires further investigation using effectiveness trials.
Clinical outcomes
Activity pacing improved across all APQ- 28 subthemes, 
the largest improvement being for Activity planning. 
This theme refers to planning activities, setting time 
targets and assessing activity levels36; practical facets of 
activity pacing which may be more accessible to change. 
Comparably, participants showed smaller improvements 
in Activity acceptance. This subtheme includes setting 
realistic goals and allowing flexibility; facets that involve 
changing previous behaviours or self- enforced rules. The 
APQ- 28 detected multidimensional changes in activity 
pacing, and the two new items appeared to complement 
the scale. Further study will fully validate the APQ- 28 in a 
larger sample and estimate minimally important changes.
The aims of the activity pacing framework are to improve 
patients’ function and quality of life. Improvements in 
physical function were seen between T1 and T2 (mean 
change=4.67) that were greater than the minimally clin-
ically important change (3.29).51 There were also reduc-
tions in avoidance between T1 and T2. It is intended that 
the quota- contingent, operant approach of the activity 
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through setting meaningful and realistic goals towards 
activity, rather than stopping activities with the aim of 
reducing/avoiding symptoms as per energy conservation 
approaches. Similarly, in an RCT comparing an operant 
approach with energy conservation, Racine et al30 found 
the operant approach, but not energy conservation was 
associated with reduced avoidance among patients with 
fibromyalgia. This, together with greater improvements in 
depressive symptoms following the operant approach over 
energy conservation, led to recommendations towards 
the operant approach for patients with fibromyalgia.30 
The current study found that pre–post treatment (T1- T2) 
improvements in both avoidance and physical function 
showed some decline at 3 months’ follow- up. The authors 
suggest that physical function may be a component of 
rehabilitation in which patients feel least confident, espe-
cially those with avoidant behaviours.20 This may have 
implications for future programmes to integrate follow- up 
sessions to encourage longer- term maintenance of phys-
ical activity. In comparison, Racine et al30 found improve-
ments in physical activity following both operant pacing 
and energy conservation approaches. Similarly to this 
study, Racine et al30 implemented handouts, homework 
and goal setting to encourage patients’ uptake of activity 
pacing. However, both of the interventions explored by 
Racine et al30 were of greater duration than the current 
study, comprising of 10 2 hour stand- alone pacing sessions 
with a 3- month booster session. Within the current study, 
improvements in mental function between T1 and T2 
(mean change=7.3) were better maintained between T1 
and T3 (mean change=5.95); and both higher than the 
minimally clinically important change (3.77).51 Quality of 
life also improved between T1 and T2 (mean change=0.13) 
and much of this improvement was maintained between 
T1 and T3 (mean change=0.07); both changes exceeded 
the minimally important difference (0.037±0.008).52
The activity pacing framework additionally aims to increase 
patients’ self- efficacy. Improvements in self- efficacy were 
found between T1 (mean=25.29) and T2 (mean=36.29), 
which were well maintained at T3 (mean=34.68). Scores 
were lower than the ≥40 cut- off. However, an improve-
ment of >5.5 was attained which is considered a minimally 
important change.53 Both physical and mental fatigue 
improved, and improvements in mental fatigue appeared 
to be better maintained at T3. Comparisons to minimally 
important changes are unavailable.
Psychological health improved following the rehabilita-
tion programme, including reduced depression scores from 
moderate to mild (T1=13.7, T2=7.1, T3=9.1); with a clinically 
significant reduction (≥5) between T1 and T2.40 Mean anxiety 
scores reduced (T1=9.9, T2=5.4 and T3=6.10), and remained 
within the classification of mild anxiety.41 Although reduc-
tions in pain were not a direct aim of the current treatment, 
lower pain severity was reported. Despite the increased inten-
sity of pacing sessions contained within the RCT comparing 
the operant approach to energy conservation, Racine et al30 
found that neither pacing approach effectively reduced 
symptoms of pain or fatigue.
Strengths and limitations
This study was an early feasibility study that primarily 
aimed to explore whether a new activity pacing frame-
work could be implemented in the clinical setting. 
While this study fulfilled its original aims, it is limited 
by the absence of a priori progression criteria. However, 
the findings from this study will help to inform the 
progression criteria that are used to determine whether 
to progress to a full clinical trial from a future pilot RCT. 
Despite recruiting to target, this sample was not powered 
with a control arm to determine treatment effectiveness. 
As per other studies exploring activity pacing, activity 
pacing was instructed as one component of the reha-
bilitation programme.5 Therefore, improvements in 
symptoms may have resulted from any combination of 
coping strategies. A future RCT will implement a suit-
able control to explore the effects of activity pacing, 
while implementing the activity pacing framework in 
a clinically relevant setting, including alongside other 
coping strategies.
The generalisability of this study is limited to a sample 
of predominantly females and white ethnic origin. 
Recruitment occurred only at one Pain Service and this 
service had an existing rehabilitation programme for 
both chronic pain and fatigue. Bias may have arisen 
through the lead researcher delivering the healthcare 
professionals’ training and undertaking the observa-
tions. Further work will test the activity pacing framework 
and study protocol across other healthcare services and 
explore feasibility and fidelity over wider geographical 
locations.
It is unknown what potential bias was caused by the 
attrition rate. However, there were no differences at base-
line between those who completed the programme and 
those who dropped out. It is possible that patients who 
completed T2 and T3 possibly felt greater benefits from 
the treatment and were more motivated to respond to 
the follow- up questionnaires. The attrition rate may be 
reflective of some of the clinical challenges and missed 
appointments surrounding the complexity of chronic 
pain/fatigue. Further research could explore whether 
providing a follow- up treatment session improves commit-
ment to activity pacing.
Modifications for future study
Since more patients completed the T1 questionnaires during 
the rehabilitation sessions than at home, this may be the 
preferable mode of distribution of paper questionnaires. To 
lessen the time taken to complete the questionnaires, the 
PASS- 20 may be considered for exclusion in future study. 
The whole 20- item PASS scale was included for reliability and 
validity, but data specifically from the Escape and Avoidance 
subscale was explored. Modifications to the inclusion criteria 
may include patients with any chronic spinal pain, including 
cervical/thoracic pain due to the frequent and similar 
presentation at rehabilitation services.
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Conclusion
To the authors’ knowledge, this is the first study to 
explore the clinical utility of a comprehensive activity 
pacing framework developed for both chronic pain and 
chronic fatigue. The newly developed activity pacing 
framework proved feasible to use clinically by healthcare 
professionals. Patients with both chronic pain and fatigue 
implemented greater activity pacing strategies following 
treatment, alongside reporting improvements in quality 
of life, psychological well- being, self- efficacy, pain and 
fatigue. Physical function and avoidance improved to a 
lesser extent and for the shorter- term. Future study will 
use the activity pacing framework in an effectiveness RCT 
to explore the effects of activity pacing on symptoms.
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